We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
-11.58%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$89.9M
AUM Growth
-$24M
(-21%)
Cap. Flow
-$5.95M
Cap. Flow
% of AUM
-6.62%
Top 10 Holdings %
Top 10 Hldgs %
32.28%
Holding
134
New
5
Increased
29
Reduced
46
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$1.21M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$1.19M |
| 3 |
ETRM
EnteroMedics Inc.
ETRM
|
+$1.14M |
| 4 |
AT&T
T
|
+$620K |
| 5 |
BCS.PRA.CL
Barclays Bank Plc Series 3
BCS.PRA.CL
|
+$492K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HILL
DOT HILL SYSTEMS CORP
HILL
|
+$3.65M |
| 2 |
Apple
AAPL
|
+$1.5M |
| 3 |
Medtronic
MDT
|
+$1.11M |
| 4 |
Quest Diagnostics
DGX
|
+$856K |
| 5 |
Johnson & Johnson
JNJ
|
+$839K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 56.04% |
| 2 | Technology | 12.92% |
| 3 | Industrials | 10.65% |
| 4 | Consumer Staples | 4.7% |
| 5 | Miscellaneous | 4.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
STJ
1
DELISTED
St Jude Medical
STJ
| $6.01M | 6.69% |
95,338
+1,050
| +1% | +$74.9K |
|
2
NeoGenomics
NEO
$2.32B
| $4.55M | 5.06% |
794,012
-2,918
| -0.4% | -$18.1K |
|
3
Rockwell Medical
RMTI
$32.9M
| $3.76M | 4.19% |
4,437
+38
| +0.9% | +$55.1K |
|
4
Axogen
AXGN
$2.77B
| $2.73M | 3.04% |
662,700
+29,450
| +5% | +$118K |
|
|
CSII
5
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.31M | 2.57% |
145,850
+47,850
| +49% | +$1.21M |
|
6
LeMaitre Vascular
LMAT
$1.84B
| $2.06M | 2.29% |
168,695
-12,110
| -7% | -$155K |
|
7
Pfizer
PFE
$159B
| $2M | 2.23% |
67,118
-263
| -0.4% | -$8.43K |
|
|
SVU
8
DELISTED
SUPERVALU Inc.
SVU
| $1.87M | 2.08% |
37,129
+786
| +2% | +$45.2K |
|
|
ASRT
9
DELISTED
Assertio
ASRT
| $1.86M | 2.08% |
1,649
+8
| +0.5% | +$13.7K |
|
10
ePlus
PLUS
$2.28B
| $1.86M | 2.07% |
94,000
-4,000
| -4% | -$76.7K |
|
11
AtriCure
ATRC
$2.47B
| $1.84M | 2.05% |
84,000
| – | – |
|
12
Deluxe
DLX
$1.08B
| $1.74M | 1.94% |
31,208
| – | – |
|
13
Eli Lilly
LLY
$1.05T
| $1.7M | 1.89% |
20,300
+100
| +0.5% | +$8.44K |
|
14
Altimmune
ALT
$605M
| $1.62M | 1.8% |
4,052
+8
| +0.2% | +$3.79K |
|
15
UnitedHealth
UNH
$353B
| $1.55M | 1.72% |
13,350
| – | – |
|
|
CGNT
16
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.54M | 1.72% |
1,244,597
+193,210
| +18% | +$296K |
|
|
JCP
17
DELISTED
J.C. Penney Company, Inc.
JCP
| $1.41M | 1.57% |
151,400
+4,000
| +3% | +$35.4K |
|
18
CVS Health
CVS
$119B
| $1.37M | 1.52% |
14,183
| – | – |
|
|
ZIXI
19
DELISTED
Zix Corporation
ZIXI
| $1.32M | 1.47% |
314,289
-2,700
| -0.9% | -$12.8K |
|
20
SPS Commerce
SPSC
$3.06B
| $1.2M | 1.33% |
35,300
+3,200
| +10% | +$112K |
|
|
HDS
21
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.15M | 1.28% |
40,150
-1,800
| -4% | -$60.4K |
|
|
BEAT
22
DELISTED
BioTelemetry, Inc.
BEAT
| $1.14M | 1.27% |
+93,450
| New | +$1.19M |
|
23
Global Payments
GPN
$24.3B
| $1.11M | 1.24% |
19,400
| – | – |
|
|
CASC
24
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.07M | 1.19% |
65,108
-2,294
| -3% | -$47K |
|
25
Idexx Laboratories
IDXX
$43.7B
| $1.04M | 1.16% |
14,000
| – | – |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Perkins Capital Management held 134 positions worth $89.9M, down 21% from $114M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management withdrew a net $5.95M in Q3 2015, closing 12 positions and reducing 46 holdings. Its most notable exit was DOT HILL SYSTEMS CORP, an estimated $3.65M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 56% of assets, up from 53% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in BioTelemetry, Inc. worth $1.14M.
- Perkins Capital Management's largest Q3 2015 buy was BioTelemetry, Inc.: 93,450 shares worth $1.14M.
- Perkins Capital Management added most to Cardiovascular Systems, Inc. in Q3 2015, an estimated $1.21M increase.
- Perkins Capital Management's biggest Q3 2015 reduction was Apple, cutting an estimated $1.5M.
- Perkins Capital Management fully exited DOT HILL SYSTEMS CORP in Q3 2015, selling an estimated $3.65M.
- Perkins Capital Management's ten largest holdings make up 32% of its $89.9M portfolio in Q3 2015.
- Perkins Capital Management opened 5 new positions and closed 12 in Q3 2015.
- Perkins Capital Management's portfolio value fell 21% quarter-over-quarter to $89.9M.
Based on Perkins Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.